Wellington Management Group’s Arcturus Therapeutics ARCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.46M | Buy |
111,907
+19,033
| +20% | +$248K | ﹤0.01% | 1642 |
|
|
2025
Q1 | $984K | Sell |
92,874
-4,162
| -4% | -$44.1K | ﹤0.01% | 1709 |
|
|
2024
Q4 | $1.65M | Buy |
97,036
+742
| +0.8% | +$12.6K | ﹤0.01% | 1606 |
|
|
2024
Q3 | $2.23M | Sell |
96,294
-264,455
| -73% | -$6.14M | ﹤0.01% | 1509 |
|
|
2024
Q2 | $8.78M | Buy |
360,749
+75,634
| +27% | +$1.84M | ﹤0.01% | 1188 |
|
|
2024
Q1 | $9.63M | Buy |
285,115
+224,274
| +369% | +$7.57M | ﹤0.01% | 1145 |
|
|
2023
Q4 | $1.92M | Buy |
60,841
+17,491
| +40% | +$551K | ﹤0.01% | 1505 |
|
|
2023
Q3 | $1.11M | Buy |
43,350
+1,098
| +3% | +$28.1K | ﹤0.01% | 1593 |
|
|
2023
Q2 | $1.21M | Sell |
42,252
-1,608
| -4% | -$46.1K | ﹤0.01% | 1577 |
|
|
2023
Q1 | $1.05M | Sell |
43,860
-115
| -0.3% | -$2.76K | ﹤0.01% | 1645 |
|
|
2022
Q4 | $746K | Sell |
43,975
-249
| -0.6% | -$4.22K | ﹤0.01% | 1717 |
|
|
2022
Q3 | $655K | Sell |
44,224
-12,124
| -22% | -$180K | ﹤0.01% | 1727 |
|
|
2022
Q2 | $887K | Buy |
56,348
+75
| +0.1% | +$1.18K | ﹤0.01% | 1699 |
|
|
2022
Q1 | $1.52M | Buy |
56,273
+5,483
| +11% | +$148K | ﹤0.01% | 1657 |
|
|
2021
Q4 | $1.88M | Buy |
+50,790
| New | +$1.88M | ﹤0.01% | 1686 |
|